Clinical Trials Browser

Phase 1 × Recurrence × Inotuzumab Ozogamicin × Clear all

NCT06863259 2026-02-18

Study of Inotuzumab Ozogamicin, Venetoclax, and Dexamethasone for Relapsed B-cell ALL

Phase 1 Recruiting

Burkitt Lymphoma, Recurrence